Literature DB >> 24664454

Novel mutations widen the phenotypic spectrum of slow skeletal/β-cardiac myosin (MYH7) distal myopathy.

Phillipa J Lamont1, William Wallefeld, David Hilton-Jones, Bjarne Udd, Zohar Argov, Alexandru C Barboi, Carsten Bonneman, Kym M Boycott, Kate Bushby, Anne M Connolly, Nicholas Davies, Alan H Beggs, Gerald F Cox, Jahannaz Dastgir, Elizabeth T DeChene, Rebecca Gooding, Heinz Jungbluth, Nuria Muelas, Johanna Palmio, Sini Penttilä, Eric Schmedding, Tiina Suominen, Volker Straub, Christopher Staples, Peter Y K Van den Bergh, Juan J Vilchez, Kathryn R Wagner, Patricia G Wheeler, Elizabeth Wraige, Nigel G Laing.   

Abstract

Laing early onset distal myopathy and myosin storage myopathy are caused by mutations of slow skeletal/β-cardiac myosin heavy chain encoded by the gene MYH7, as is a common form of familial hypertrophic/dilated cardiomyopathy. The mechanisms by which different phenotypes are produced by mutations in MYH7, even in the same region of the gene, are not known. To explore the clinical spectrum and pathobiology, we screened the MYH7 gene in 88 patients from 21 previously unpublished families presenting with distal or generalized skeletal muscle weakness, with or without cardiac involvement. Twelve novel mutations have been identified in thirteen families. In one of these families, the father of the proband was found to be a mosaic for the MYH7 mutation. In eight cases, de novo mutation appeared to have occurred, which was proven in four. The presenting complaint was footdrop, sometimes leading to delayed walking or tripping, in members of 17 families (81%), with other presentations including cardiomyopathy in infancy, generalized floppiness, and scoliosis. Cardiac involvement as well as skeletal muscle weakness was identified in nine of 21 families. Spinal involvement such as scoliosis or rigidity was identified in 12 (57%). This report widens the clinical and pathological phenotypes, and the genetics of MYH7 mutations leading to skeletal muscle diseases.
© 2014 WILEY PERIODICALS, INC.

Entities:  

Keywords:  Laing distal myopathy; MPD1; MYH7

Mesh:

Substances:

Year:  2014        PMID: 24664454      PMCID: PMC4112555          DOI: 10.1002/humu.22553

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  46 in total

1.  Novel mutation in MYH7 gene associated with distal myopathy and cardiomyopathy.

Authors:  Houman Homayoun; Simin Khavandgar; Jacqueline M Hoover; Al-Walid Mohsen; Jerry Vockley; David Lacomis; Paula R Clemens
Journal:  Neuromuscul Disord       Date:  2011-01-05       Impact factor: 4.296

2.  Mapping of a myosin-binding domain and a regulatory phosphorylation site in M-protein, a structural protein of the sarcomeric M band.

Authors:  W M Obermann; P F van der Ven; F Steiner; K Weber; D O Fürst
Journal:  Mol Biol Cell       Date:  1998-04       Impact factor: 4.138

3.  The second kindred with autosomal dominant distal myopathy linked to chromosome 14q: genetic and clinical analysis.

Authors:  Peter Hedera; Elizabeth M Petty; Melanie R Bui; Mila Blaivas; John K Fink
Journal:  Arch Neurol       Date:  2003-09

4.  Laing early onset distal myopathy: slow myosin defect with variable abnormalities on muscle biopsy.

Authors:  P J Lamont; B Udd; F L Mastaglia; M de Visser; P Hedera; T Voit; L R Bridges; V Fabian; A Rozemuller; N G Laing
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08-15       Impact factor: 10.154

5.  A novel MYH7 mutation with prominent paraspinal and proximal muscle involvement.

Authors:  Jin-Mo Park; Ye Jin Kim; Jeong Hyun Yoo; Young Bin Hong; Ji Hoon Park; Heasoo Koo; Ki Wha Chung; Byung-Ok Choi
Journal:  Neuromuscul Disord       Date:  2013-05-24       Impact factor: 4.296

6.  Autosomal dominant distal myopathy: further evidence of a chromosome 14 locus.

Authors:  T Voit; P Kutz; B Leube; E Neuen-Jacob; J M Schröder; D Cavallotti; M L Vaccario; J Schaper; P Broich; R Cohn; M Baethmann; G Göhlich-Ratmann; C Scoppetta; R Herrmann
Journal:  Neuromuscul Disord       Date:  2001-01       Impact factor: 4.296

Review 7.  Cardiomyopathy: a systematic review of disease-causing mutations in myosin heavy chain 7 and their phenotypic manifestations.

Authors:  R Walsh; C Rutland; R Thomas; S Loughna
Journal:  Cardiology       Date:  2009-10-27       Impact factor: 1.869

8.  Actin mutations are one cause of congenital fibre type disproportion.

Authors:  Nigel G Laing; Nigel F Clarke; Danielle E Dye; Khema Liyanage; Kendall R Walker; Yasuaki Kobayashi; Shuichi Shimakawa; Tohru Hagiwara; Robert Ouvrier; John C Sparrow; Ichizo Nishino; Kathryn N North; Ikuya Nonaka
Journal:  Ann Neurol       Date:  2004-11       Impact factor: 10.422

9.  Mutations at the same amino acid in myosin that cause either skeletal or cardiac myopathy have distinct molecular phenotypes.

Authors:  Thomas Z Armel; Leslie A Leinwand
Journal:  J Mol Cell Cardiol       Date:  2009-10-23       Impact factor: 5.000

10.  Novel myosin heavy chain immunohistochemical double staining developed for the routine diagnostic separation of I, IIA and IIX fibers.

Authors:  Olayinka Raheem; Sanna Huovinen; Tiina Suominen; Hannu Haapasalo; Bjarne Udd
Journal:  Acta Neuropathol       Date:  2010-01-28       Impact factor: 17.088

View more
  29 in total

Review 1.  Role of circular RNAs in cardiovascular diseases.

Authors:  Xue Gong; Gengze Wu; Chunyu Zeng
Journal:  Exp Biol Med (Maywood)       Date:  2019-01-17

2.  Drosophila model of myosin myopathy rescued by overexpression of a TRIM-protein family member.

Authors:  Martin Dahl-Halvarsson; Montse Olive; Malgorzata Pokrzywa; Katarina Ejeskär; Ruth H Palmer; Anne Elisabeth Uv; Homa Tajsharghi
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-26       Impact factor: 11.205

3.  A new early-onset neuromuscular disorder associated with kyphoscoliosis peptidase (KY) deficiency.

Authors:  Carola Hedberg-Oldfors; Niklas Darin; Mia Olsson Engman; Zacharias Orfanos; Christer Thomsen; Peter F M van der Ven; Anders Oldfors
Journal:  Eur J Hum Genet       Date:  2016-08-03       Impact factor: 4.246

4.  Defective sarcomere organization and reduced larval locomotion and fish survival in slow muscle heavy chain 1 (smyhc1) mutants.

Authors:  Siping Li; Haishen Wen; Shaojun Du
Journal:  FASEB J       Date:  2019-12-01       Impact factor: 5.191

Review 5.  Pathophysiological concepts in the congenital myopathies: blurring the boundaries, sharpening the focus.

Authors:  Gianina Ravenscroft; Nigel G Laing; Carsten G Bönnemann
Journal:  Brain       Date:  2014-12-31       Impact factor: 13.501

Review 6.  Skeletal muscle fiber type: using insights from muscle developmental biology to dissect targets for susceptibility and resistance to muscle disease.

Authors:  Jared Talbot; Lisa Maves
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2016-05-19       Impact factor: 5.814

7.  A composite approach towards a complete model of the myosin rod.

Authors:  E Nihal Korkmaz; Keenan C Taylor; Michael P Andreas; Guatam Ajay; Nathan T Heinze; Qiang Cui; Ivan Rayment
Journal:  Proteins       Date:  2015-12-09

8.  Mutation update: the spectra of nebulin variants and associated myopathies.

Authors:  Vilma-Lotta Lehtokari; Kirsi Kiiski; Sarah A Sandaradura; Jocelyn Laporte; Pauliina Repo; Jennifer A Frey; Kati Donner; Minttu Marttila; Carol Saunders; Peter G Barth; Johan T den Dunnen; Alan H Beggs; Nigel F Clarke; Kathryn N North; Nigel G Laing; Norma B Romero; Thomas L Winder; Katarina Pelin; Carina Wallgren-Pettersson
Journal:  Hum Mutat       Date:  2014-12       Impact factor: 4.878

Review 9.  Congenital myopathies: disorders of excitation-contraction coupling and muscle contraction.

Authors:  Heinz Jungbluth; Susan Treves; Francesco Zorzato; Anna Sarkozy; Julien Ochala; Caroline Sewry; Rahul Phadke; Mathias Gautel; Francesco Muntoni
Journal:  Nat Rev Neurol       Date:  2018-02-02       Impact factor: 42.937

Review 10.  Molecular and cellular basis of genetically inherited skeletal muscle disorders.

Authors:  James J Dowling; Conrad C Weihl; Melissa J Spencer
Journal:  Nat Rev Mol Cell Biol       Date:  2021-07-13       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.